Sarcopenia influences usage of reperfusion treatment in patients with pulmonary embolism aged 75 years and older

Sarcopenia influences usage of reperfusion treatment in patients with pulmonary embolism aged 75 years and older

Background: Although pulmonary embolism (PE) and sarcopenia are common diseases, only a few studies have assessed the impact of sarcopenia in PE on usage of reperfusion treatments in PE. Methods: All hospitalizations of PE patients aged ≥75 years 2005–2020 in Germany were included in this study and...

Full description

Bibliographic Details
Main Authors: Karsten Keller, Volker H. Schmitt, Christoph Brochhausen, Omar Hahad, Martin Engelhardt, Christine Espinola-Klein, Thomas Münzel, Philipp Lurz, Stavros Konstantinides, Lukas Hobohm
Format: Article
Language:English
Published: Elsevier 2024-08-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Pulmonary embolism
Sarcopenia
Clinical outcome
Epidemiology
Frailty
Skeletal muscle impairment
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906724001362

Internet

http://www.sciencedirect.com/science/article/pii/S2352906724001362

Similar Items